StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Vertex (VRTX) PT Raised to $204 at BMO Capital; 'Stellar Revenue'
July 26, 2018 7:11 AM
BMO Capital raised its price target on Vertex (NASDAQ: VRTX) to $204.00 (from $191.00) while maintaining an Outperform rating following ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
Vertex (VRTX) PT Raised to $211 at Morgan Stanley
July 26, 2018 9:03 AM
Vertex (VRTX) PT Raised to $203 at RBC Capital
July 26, 2018 8:44 AM
Vertex (VRTX) PT Raised to $188 at UBS
July 26, 2018 7:07 AM
Vertex (VRTX) PT Raised to $200 at Oppenheimer
July 26, 2018 6:59 AM
Form 8-K VERTEX PHARMACEUTICALS For: Jul 25
July 25, 2018 4:09 PM
Vertex Pharma (VRTX) Tops Q2 EPS by 19c; Raises Outlook
July 25, 2018 4:03 PM
Vertex Reports Second-Quarter 2018 Financial Results
July 25, 2018 4:01 PM
